NCI
California Bill Aims to Give Medi-Cal Patients With Complex Cancers Access to Cutting-Edge Care
Premium
If passed, the bill would require Medi-Cal managed care plans to include in contracted provider networks at least one NCI-designated comprehensive cancer center.
International LAGENO-BC Consortium Spurring Breast Cancer Genetics Research Across Latin America
Premium
The consortium, which includes 13 studies in seven countries, was formed to support breast cancer genetic research across Latin American and Hispanic populations.
Preclinical Data In Hand, City of Hope to Study Anti-TAG72 CAR T-Cell Therapy for Ovarian Cancer
At AACR, researchers described plans for an upcoming trial of an autologous CAR T-cell therapy infused directly into the peritoneal cavity of epithelial ovarian cancer patients.
New Epigenomic Biomarker Could Predict CAR T-Cell Therapy Resistance in Advanced Childhood Leukemia
Premium
At AACR, researchers described how pediatric ALL patients who don't respond to anti-CD19 CAR T-cell therapy have cancers with a unique, stem cell-like epigenome.
Multiple successor trials are in the works based on hits, misses, and overall knowledge gained from one of the first precision medicine platform trials.